Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry notes that NOC-110 is being studied in a Phase 2 trial for adults with refractory or unexplained chronic cough, and the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• NOC-110

Snippet

Sponsor: Nocion Therapeutics | Conditions: Refractory or Unexplained Chronic Cough | Phase 2 | Status: RECRUITING